GB9820956D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9820956D0
GB9820956D0 GBGB9820956.2A GB9820956A GB9820956D0 GB 9820956 D0 GB9820956 D0 GB 9820956D0 GB 9820956 A GB9820956 A GB 9820956A GB 9820956 D0 GB9820956 D0 GB 9820956D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9820956.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9820956.2A priority Critical patent/GB9820956D0/en
Publication of GB9820956D0 publication Critical patent/GB9820956D0/en
Priority to PL99354714A priority patent/PL354714A1/en
Priority to EP99915735A priority patent/EP1069910A1/en
Priority to NZ506603A priority patent/NZ506603A/en
Priority to KR1020007011240A priority patent/KR20010042573A/en
Priority to TR2000/02930T priority patent/TR200002930T2/en
Priority to BR9909915-2A priority patent/BR9909915A/en
Priority to IL13800099A priority patent/IL138000A0/en
Priority to HU0101619A priority patent/HUP0101619A3/en
Priority to CN99804894A priority patent/CN1296416A/en
Priority to JP2000543159A priority patent/JP2002511423A/en
Priority to CA002325939A priority patent/CA2325939A1/en
Priority to AU34197/99A priority patent/AU746163B2/en
Priority to PCT/EP1999/002278 priority patent/WO1999052549A1/en
Priority to ARP990101567A priority patent/AR019026A1/en
Priority to NO20005051A priority patent/NO20005051L/en
Ceased legal-status Critical Current

Links

GBGB9820956.2A 1998-04-09 1998-09-25 Vaccine Ceased GB9820956D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB9820956.2A GB9820956D0 (en) 1998-09-25 1998-09-25 Vaccine
PCT/EP1999/002278 WO1999052549A1 (en) 1998-04-09 1999-03-29 Adjuvant compositions
BR9909915-2A BR9909915A (en) 1998-04-09 1999-03-29 Adjuvant compositions
HU0101619A HUP0101619A3 (en) 1998-04-09 1999-03-29 Adjuvant compositions
NZ506603A NZ506603A (en) 1998-04-09 1999-03-29 Adjuvant compositions comprising polyoxyethylene ether or polyoxyethylene ester
KR1020007011240A KR20010042573A (en) 1998-04-09 1999-03-29 Adjuvant compositions
TR2000/02930T TR200002930T2 (en) 1998-04-09 1999-03-29 Facilitating compositions
PL99354714A PL354714A1 (en) 1998-04-09 1999-03-29 Adjuvant compositions
IL13800099A IL138000A0 (en) 1998-04-09 1999-03-29 Adjuvant compositions
EP99915735A EP1069910A1 (en) 1998-04-09 1999-03-29 Adjuvant compositions
CN99804894A CN1296416A (en) 1998-04-09 1999-03-29 Adjuvant compositions
JP2000543159A JP2002511423A (en) 1998-04-09 1999-03-29 vaccine
CA002325939A CA2325939A1 (en) 1998-04-09 1999-03-29 Vaccine
AU34197/99A AU746163B2 (en) 1998-04-09 1999-03-29 Adjuvant compositions
ARP990101567A AR019026A1 (en) 1998-04-09 1999-04-07 ADJUSTMENT COMPOSITION THAT INCLUDES A SURFACTANT, ADJUSTMENT COMBINATION THAT UNDERSTANDS IT, VACCINE COMPOSITION THAT UNDERSTANDS THEM, USE OF THE DICHOSURFACTANT AND SUCH COMPOSITION TO MANUFACTURE OF VACCINE COMPOSITION, ROUND ROLLING METHOD, COMPONENT USE OF VACCINE
NO20005051A NO20005051L (en) 1998-04-09 2000-10-06 Adjuvantsammensetninger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9820956.2A GB9820956D0 (en) 1998-09-25 1998-09-25 Vaccine

Publications (1)

Publication Number Publication Date
GB9820956D0 true GB9820956D0 (en) 1998-11-18

Family

ID=10839508

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9820956.2A Ceased GB9820956D0 (en) 1998-04-09 1998-09-25 Vaccine

Country Status (1)

Country Link
GB (1) GB9820956D0 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1961819A2 (en) 2000-06-28 2008-08-27 Corixa Corporation Composition and methods for the therapy and diagnosis of lung cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1961819A2 (en) 2000-06-28 2008-08-27 Corixa Corporation Composition and methods for the therapy and diagnosis of lung cancer

Similar Documents

Publication Publication Date Title
IL140094A0 (en) Vaccine
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341698A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
PL343065A1 (en) Vaccine composition
HUP0105392A3 (en) Enhanced vaccines
GB9822714D0 (en) Vaccines
PL344519A1 (en) Vaccine
GB9801870D0 (en) Vaccine composition
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9807805D0 (en) Vaccine
GB9809958D0 (en) Vaccine
GB9805960D0 (en) Vaccine
GB9802543D0 (en) Vaccine
GB9822712D0 (en) Vaccine
GB9822709D0 (en) Vaccine
GB9822703D0 (en) Vaccine
GB9812773D0 (en) Vaccine
GB9802544D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9802650D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)